Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meredith S Irwin

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Cancer Biology & Therapy|August 22, 2006
DeltaNp73: misunderstood protein?Meredith S Irwin
Cell Cycle (Georgetown, Tex.)|January 24, 2004
Family feud in chemosensitvity: p73 and mutant p53Meredith S Irwin
Oncotarget|August 12, 2014
Spy'ing on differentiation in neuroblastomaMonika Podkowa, Meredith S Irwin
JAMA|August 28, 2019
Tandem Transplant for High-Risk Neuroblastoma: Next Steps in the Era of Precision MedicineRochelle Bagatell, Meredith S Irwin
Pediatric Blood & Cancer|October 21, 2016
Measuring primary tumor response in neuroblastoma: More than using a rulerPaola Angelini, Meredith S Irwin
Journal of the National Comprehensive Cancer Network : JNCCN|August 16, 2024
Current and Emerging Biomarkers: Impact on Risk Stratification for NeuroblastomaMeredith S Irwin, Kelly C Goldsmith
Neoplasia (New York, N.Y.)|August 24, 2006
Ubiquitin and ubiquitin-like modifications of the p53 familyIan R Watson, Meredith S Irwin
Pediatric Clinics of North America|December 2, 2014
Neuroblastoma: paradigm for precision medicineMeredith S Irwin, Julie R Park
Cancer Cell|February 15, 2011
NEDD8 pathways in cancer, Sine Quibus NonIan R Watson, Meredith S Irwin, Michael Ohh
American Journal of Ophthalmology|February 2, 2020
Incidence and Prognostic Role of the Ocular Manifestations of Neuroblastoma in ChildrenSybille Graef, Meredith S Irwin, Michael J Wan
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Cancer Biology & Therapy|August 22, 2006
DeltaNp73: misunderstood protein?Meredith S Irwin
Cell Cycle (Georgetown, Tex.)|January 24, 2004
Family feud in chemosensitvity: p73 and mutant p53Meredith S Irwin
Oncotarget|August 12, 2014
Spy'ing on differentiation in neuroblastomaMonika Podkowa, Meredith S Irwin
JAMA|August 28, 2019
Tandem Transplant for High-Risk Neuroblastoma: Next Steps in the Era of Precision MedicineRochelle Bagatell, Meredith S Irwin
Pediatric Blood & Cancer|October 21, 2016
Measuring primary tumor response in neuroblastoma: More than using a rulerPaola Angelini, Meredith S Irwin
Journal of the National Comprehensive Cancer Network : JNCCN|August 16, 2024
Current and Emerging Biomarkers: Impact on Risk Stratification for NeuroblastomaMeredith S Irwin, Kelly C Goldsmith
Neoplasia (New York, N.Y.)|August 24, 2006
Ubiquitin and ubiquitin-like modifications of the p53 familyIan R Watson, Meredith S Irwin
Pediatric Clinics of North America|December 2, 2014
Neuroblastoma: paradigm for precision medicineMeredith S Irwin, Julie R Park
Cancer Cell|February 15, 2011
NEDD8 pathways in cancer, Sine Quibus NonIan R Watson, Meredith S Irwin, Michael Ohh
American Journal of Ophthalmology|February 2, 2020
Incidence and Prognostic Role of the Ocular Manifestations of Neuroblastoma in ChildrenSybille Graef, Meredith S Irwin, Michael J Wan
Pageof 13